OregenX is leading innovation in organoid technology, dedicated to building a new paradigm of precision medicine driven by patient-specific organoid models. We customize high-fidelity disease models and drug testing platforms to enhance clinical translation for pharmaceutical R&D and develop tools to realize personalized treatment. Currently, we have established a collection of organoids covering various organs and diseases, secured multiple core patented technologies, and are actively advancing the full value chain from drug screening to organ regeneration therapies.